/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2025-02-19-14-57-10-864-67b5f146143d887bc4dda20b.png)
A recent EU directive will have significant consequences for Australian life sciences companies operating in Europe. Directive 2024/2853...
BioTalk
Powered by Bird & Bird
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2025-02-14-09-07-01-744-67af07b54a695cb0139e3eb3.png)
A new European directive is set to significantly impact pharmaceutical companies operating within the European Union. Directive (EU)...
/Passle/MediaLibrary/Images/2025-01-24-08-52-14-331-679354be3100ad445216c2a5.PNG)
The Dutch Medicines Evaluation Board (MEB) has recently published a new policy for Compassionate Use Programmes (CUP).[1] To support the...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-10-15-07-08-25-298-670e14e9b3157324cf24ba0c.jpg)
On 24 September, the French National Agency for the Safety of Medicines and Health Products (ANSM) announced fines totalling €8 million...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-10-09-13-34-10-162-67068652a75ae96e1ecfeab1.png)
The CJEU brings clarity, on the concepts of “Significant Benefit” and “Clinical Superiority” with respect to Orphan Medicinal Products...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-09-17-11-36-19-180-66e969b30513207aadd84e6a.jpg)
The life sciences sector, comprising of sub-sectors like pharmaceuticals, medical devices, diagnostics and services, aims to cure disease...
/Passle/MediaLibrary/Images/2024-08-02-14-59-30-386-66acf45250478b62ec64232d.jpg)
Introduction to the EU Pharmaceutical Reform After the European Commission published the proposed regulation regarding the EU...
/Passle/MediaLibrary/Images/2024-07-30-14-32-46-741-66a8f98e926269fa77476cf4.jpg)
The UK life sciences industry takes centre-stage in two of the new Labour government’s “Five Missions For National Renewal”: economic...